Germany funds white research

Williams, Dede; Gibson, Jane
October 2006
ICIS Chemical Business;10/30/2006, Vol. 1 Issue 41, p11
Trade Publication
The article reports on the agreement of Germany's federal government to support industrial or white biotechnology research to the tune of up to €60m over the next five years from 2006. The money, which is part of a research and development aid package to be passed by the cabinet of Chancellor Angela Merkel, will help fund industry-initiated projects estimated to cost more than €150m.


Related Articles

  • Japan's industrial R&D spending revives, as rising international competition puts premium on... Yoshida, Phyllis Genther; Wolff, M.F. // Research Technology Management;Jan/Feb98, Vol. 41 Issue 1, p2 

    Reports on the growth of the Japanese industrial research and development (R&D) spending for the fiscal year 1995, covering the period between April 1995 to March 1996. Percentage increase of R&D spending; Sectors performing well despite the economy's sluggishness; Researchers' efforts to...

  • Federal funding and the level of private expenditure on basic research. Robson, Martin T. // Southern Economic Journal;Jul93, Vol. 60 Issue 1, p63 

    Examines the role of government-funded industrial research and development (R&D) activity in stimulating or substituting for private-sector expenditure on R&D. Use of aggregate time series data; Analytical framework; Determination of `supply price' and `demand price'; Effect of increased sales...

  • The State of Global R&D. Duga, Jules; Studt, Tim; Dearing, Andrew // R&D Magazine;Sep2005, Vol. 47 Issue 9, pG1 

    Focuses on the trends affecting total funding and the distribution of funding for research and development. Source of funds for the performance of research and development by industry; Role of government in supporting or promoting research and development; Changes in the structure of the...

  • What to do with a $2.9 trillion surplus? Spend It. Bluestone, Barry // New Republic;08/09/99, Vol. 221 Issue 6, p23 

    The article presents the author's views on the use of the U.S. federal budget surplus. According to the author, a fair share of the budget surplus should be spend on public investment in research and development (R&D), infrastructure, and education and training. The public sector has played a...

  • 2007 R&D Funding Forecast.  // R&D Magazine;Jan2007, Vol. 49 Issue 1, pF1 

    The article presents a forecast on research and development (R&D) funding in the U.S. in 2007. Industrial R&D is expected to increase 3.4 percent in 2007. The defense spending of the government is projected to achieve a 4.8 percent growth. R&D performance in the future is still affected by...

  • IBM shifts semiconductor research strategy. Sperling, Ed // Electronic News;6/25/2007, Vol. 53 Issue 26, p2 

    The article reports on the decision of IBM to change the way it does microprocessor research. The move is aimed at creating real chips very early in the process so that it can determine what technologies work and what is likely to cause yield problems. Bernard Meyerson, chief technologist at...

  • On the rebound. Roberts, Peter // BRW;8/30/2007, Vol. 29 Issue 34, p33 

    The article discusses the need for the Australian government to promote increased business expenditure on research and development (BERD) in order to remain competitive with other prosperous nations. According to the author, Australian BERD, which is 1.04 percent of the economy in the 2005-2006...

  • Stronger funding role for industry marks turning point in R&D. Studt, Tim // R&D Magazine;Jan96, Vol. 38 Issue 1, p21 

    Focuses on the 1996 growth forecast in industrial research and development in the United States. Increase in overall investment in research and development (R&D); Government's role in research and development; High-tech industries funding R&D growth; Annual R&D trends issued by the US...

  • Financing Comes Full Circle; R&DLP Resurgence in Works? Morrison, Trista // BioWorld Today;11/11/2010, Vol. 21 Issue 219, p1 

    The article discusses the possible reemergence of research and development limited partnerships (R&DLP) for funding projects in the biotechnology industry. The R&DLP allowed private investors to purchase a drug candidate, hire the biotechnology company to continue development and give the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics